Drug Shortage Report for TEVA-ECTOSONE

Last updated on 2024-03-18 History
Report ID 195634
Drug Identification Number 00750050
Brand name TEVA-ECTOSONE
Common or Proper name TEVA-ECTOSONE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BETAMETHASONE
Strength(s) 0.1%
Dosage form(s) LOTION
Route of administration TOPICAL TOPICAL
Packaging size 60ML
ATC code D07AC
ATC description CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-06-19
Estimated end date 2024-03-10
Actual end date 2024-03-10
Shortage status Resolved
Updated date 2024-03-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2024-03-18 French Compare
v16 2024-03-18 English Compare
v15 2024-03-18 French Compare
v14 2024-03-18 English Compare
v13 2024-01-25 French Compare
v12 2024-01-25 English Compare
v11 2024-01-18 French Compare
v10 2024-01-18 English Compare
v9 2023-10-04 French Compare
v8 2023-10-04 English Compare
v7 2023-08-03 French Compare
v6 2023-08-03 English Compare
v5 2023-07-11 French Compare
v4 2023-07-11 English Compare
v3 2023-06-20 English Compare
v2 2023-06-19 French Compare
v1 2023-06-19 English Compare

Showing 1 to 17 of 17